Citi Starts Arrowhead Pharma (ARWR) at Neutral, 'Awaiting Data for Intriguing Early-Stage Assets'
Tweet Send to a Friend
(Updated - September 19, 2023 4:31 AM EDT)
Citi analyst David Lebowitz initiates coverage on Arrowhead Pharma (NASDAQ: ARWR) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Citi analyst David Lebowitz initiates coverage on Arrowhead Pharma (NASDAQ: ARWR) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
